Mavacamten will lower the level or outcome of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Progestin and ethinyl estradiol are CYP3A4 substrates. Mavacamten may perhaps lower systemic exposures of ethinyl estradiol and progestin, which can lead to contraceptive failure or a rise in https://wymzyafebirthcontrol13456.pages10.com/wymzya-fe-an-overview-65914176